A range of conditions including #GuillainBarré syndrome, #CognitiveDeficit, #insomnia, #anxiety disorder, #encephalitis, ischaemic #stroke and #MoodDisorder exhibited a pronounced increase in long-term risk. Factors such as mild severity of #COVID19, increased #vaccination against COVID-19 and #heterologous vaccination were associated with reduced long-term risk of adverse neuropsychiatric outcomes. (2/3)